688382 益方生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-10.436-12.614-13.482-33.344-42.224
总资产报酬率 ROA (%)-9.844-11.766-12.593-30.718-38.433
投入资产回报率 ROIC (%)-10.282-12.326-13.184-32.699-41.509

边际利润分析
销售毛利率 (%)86.82397.675100.000----
营业利润率 (%)-586.681-142.309-153.064----
息税前利润/营业总收入 (%)-652.537-160.553-171.402----
净利润/营业总收入 (%)-587.131-142.309-153.064----

收益指标分析
经营活动净收益/利润总额(%)96.605100.447100.12799.987101.343
价值变动净收益/利润总额(%)-1.061-0.541-2.3100.0000.000
营业外收支净额/利润总额(%)0.0000.0000.0000.0370.000

偿债能力分析
流动比率 (X)21.28120.78413.41420.4077.500
速动比率 (X)21.28120.78413.41420.4077.500
资产负债率 (%)5.6135.7287.6165.66114.963
带息债务/全部投入资本 (%)0.3620.3982.6850.5191.052
股东权益/带息债务 (%)27,217.49924,778.2933,612.72618,978.0229,119.540
股东权益/负债合计 (%)1,681.5221,645.6581,213.0981,666.552568.316
利息保障倍数 (X)9.9098.8009.34714.3814,583.691

营运能力分析
应收账款周转天数 (天)1,435.372364.614342.611----
存货周转天数 (天)0.0000.000------